CNGA3 rs10865016: Understanding Your Genetic Variant
The rs10865016 variant is a single-nucleotide polymorphism located within the CNGA3 gene. This gene is essential for proper retinal function, and variations here are frequently studied for their potential influence on color vision and light sensitivity.
What each genotype means
Typical CNGA3 variant profile
This genotype represents the common sequence at this position in the CNGA3 gene. Research into this specific variant (rs10865016) does not indicate a direct association with clinical conditions like achromatopsia or cone dystrophy. While the CNGA3 gene is critical for color vision, this specific SNP is generally considered a common variation without known functional impact on retinal health.
This genotype is common in many global populations, consistent with the reported minor allele frequency.
Typical CNGA3 variant profile
This genotype represents a common heterozygous variation at this position in the CNGA3 gene. There is no evidence in current scientific literature to suggest that carrying one copy of the G allele at this location affects color vision or retinal function. This variant is distinct from the rare, pathogenic mutations in CNGA3 that are known to cause inherited retinal disorders.
This genotype is frequently observed across diverse ancestral groups, reflecting the common nature of this variant.
Typical CNGA3 variant profile
This genotype represents the alternative common sequence at this position in the CNGA3 gene. Current research does not link this specific genotype to any clinical phenotype or impairment of cone photoreceptor function. It is considered a normal variation within the human population rather than a disease-causing mutation.
This genotype is found in a significant portion of the population, consistent with the reported minor allele frequency of approximately 0.25.
What is rs10865016?
The rs10865016 variant is a specific genetic marker, or single-nucleotide polymorphism (SNP), situated within the sequence of the CNGA3 gene. In genetics, a SNP represents a variation at a single position in the DNA chain. This particular variant is located on chromosome 2 and is of interest to researchers because of its proximity to functional regions of the gene that govern how our eyes process light. While many SNPs have no observable effect on human health, researchers track variants like rs10865016 to understand how subtle changes in our genetic code might correlate with differences in sensory perception or susceptibility to specific ocular conditions. It is important to note that the presence of a specific SNP does not automatically imply a clinical diagnosis, but rather serves as a data point in the broader study of human genetic diversity and retinal biology.
The Role of the CNGA3 Gene
The CNGA3 gene provides the instructions for building the alpha subunit of the cyclic nucleotide-gated (CNG) ion channel. These channels are found exclusively in cone photoreceptor cells, which are the specialized cells in the retina responsible for color vision and high-acuity sight in bright light. When light hits the retina, these channels open or close to help convert light signals into electrical impulses that the brain interprets as images. If the CNGA3 gene is altered, the resulting CNG channels may not function correctly, which can impair the ability of cone cells to respond to light. Because these channels are so critical for the phototransduction cascade—the process of turning light into vision—mutations in this gene are well-documented as a primary cause of achromatopsia, a condition characterized by reduced visual acuity, light sensitivity, and impaired color discrimination.
Research and Evidence
Scientific research into the CNGA3 gene is robust, particularly regarding its role in congenital retinal disorders. Studies have identified hundreds of variants within this gene that can lead to significant clinical outcomes, such as achromatopsia. While rs10865016 is frequently monitored in genetic studies, the strength of evidence linking this specific SNP to a clinical diagnosis is considered moderate compared to known pathogenic mutations that directly disrupt protein function. Current research often utilizes this variant as a marker in broader studies of retinal health and color vision variation. Because the evidence is nuanced, it is essential to distinguish between common genetic variation and rare, highly penetrant mutations. Researchers continue to investigate how such variants might interact with other genetic and environmental factors to influence individual differences in visual perception.
Population Frequency
The frequency of genetic variants can vary significantly across different ancestral populations. For rs10865016, the Global Minor Allele Frequency (GMAF) is approximately 0.2548. This indicates that the variant is relatively common in the general population. Because this frequency is based on large-scale genomic databases, it reflects a broad average; however, specific ethnic or geographic groups may show higher or lower prevalence. Understanding these frequencies is a standard part of genomic research, as it helps scientists determine whether a variant is a rare mutation associated with a specific disease or a common polymorphism that contributes to normal human variation. If you are interested in how your own genetic profile compares to these population averages, this information is typically provided in the context of broader ancestry or health-trait reports.
What You Can Do With This Information
Information about your genetic variants, such as rs10865016, is primarily educational. It provides a window into your biological makeup but should not be used to diagnose or treat any medical condition. If you have concerns about your vision, color perception, or light sensitivity, the most important step is to consult with an eye care professional, such as an ophthalmologist or optometrist. They can perform clinical examinations that are far more accurate than genetic testing for assessing your actual visual function. Genetic data can be complex, and its interpretation often requires professional expertise to distinguish between benign variations and those that might have clinical significance. Always discuss any findings from genetic reports with a qualified healthcare provider who can place the information in the context of your personal and family medical history.
How common is this variant?
The rs10865016 variant has a Global Minor Allele Frequency (GMAF) of 0.2548, making it a common polymorphism across diverse human populations.
Frequently asked questions
Is rs10865016 a cause of color blindness?
While the CNGA3 gene is associated with color vision disorders like achromatopsia, rs10865016 is a common variant and is not typically classified as a primary cause of clinical color blindness. Most cases of color vision deficiency are linked to specific, rare mutations that significantly disrupt protein function.
Should I be worried if I have the AA genotype?
No, the presence of a specific genotype for a common SNP like rs10865016 does not indicate a medical problem. It is simply a variation in your DNA sequence that is shared by many people in the general population.
Can I use this information to improve my vision?
No, genetic information regarding this SNP cannot be used to improve or change your vision. If you are experiencing vision changes, you should schedule an appointment with an eye doctor for a comprehensive eye exam.
Where can I find more information about my CNGA3 gene?
You can learn more about the function of the CNGA3 gene through reputable resources like MedlinePlus Genetics. For specific questions about your own genetic data, consult with a genetic counselor or your primary care physician.
Sources & further reading
Educational information only, last refreshed 9/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10865016?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29